Results 21 to 30 of about 1,152,519 (197)

Infection with chikungunya virus confers heterotypic cross-neutralizing antibodies and memory B-cells against other arthritogenic alphaviruses predominantly through the B domain of the E2 glycoprotein.

open access: yesPLoS Neglected Tropical Diseases, 2023
Infections with Chikungunya virus, a mosquito-borne alphavirus, cause an acute febrile syndrome often followed by chronic arthritis that persists for months to years post-infection.
John M Powers   +12 more
doaj   +1 more source

Detection of chikungunya virus in the Southern region, Saudi Arabia

open access: yesVirology Journal, 2021
Background and aim Despite the fact that the chikungunya viral infection is a neglected disease, complications such as hemorrhagic fever, arthritis, and lymphopenia remain a health concern.
Abdulrahim R. Hakami   +14 more
doaj   +1 more source

Mouse Models of Chikungunya Virus

open access: yes, 2016
The majority of medical advances have been made using animals. Studies using mouse models of chikungunya-induced disease have proven invaluable for dissecting the intricate nature of the immune response to this viral infection and identifying potential ...
Stefan Wolf   +9 more
core   +1 more source

Intensive Care Admissions for Severe Chikungunya Virus Infection, French Polynesia

open access: yesEmerging Infectious Diseases, 2018
During the 2014–2015 chikungunya outbreak in French Polynesia, 64 patients with confirmed chikungunya virus infection were admitted into intensive care.
Adrien Koeltz   +2 more
doaj   +1 more source

Emergence of Chikungunya Virus in Pakistan: What should be done?

open access: yesJournal of Bahria University Medical and Dental College, 2021
Since 10 years, Chikungunya – a virus spread through Aedes spp mosquitoes – has reemerged in Africa, southern and southeastern Asia, and the Indian Ocean Islands.1 In South- East Asia, epidemics have been documented in India, Malaysia, Sri Lanka ...
Abbas Ali Hussain, Rabia Sarwar
doaj   +1 more source

Frequency of Chikungunya Virus Infection in the Tertiary Care Hospital of Karachi

open access: yesJournal of Islamic International Medical College, 2021
Objective: To determine the frequency of Chikungunya virus infection in the tertiary care hospital of Karachi during the time from 1stJanuary 2017 till 31st December 2018. Study Design: This was a retrospective cross-sectional study.
Fouzia Zeeshan Khan, Fatima Fasih, Mohammad Sohaib Tauheed, Saba Hassan, Sambreen Zameer
doaj  

Risk of chronic arthralgia and impact of pain on daily activities in a cohort of patients with chikungunya virus infection from Brazil

open access: yesInternational Journal of Infectious Diseases, 2021
Objectives: To investigate risk factors for persistent arthralgia in patients with chikungunya, and describe its impact on daily activities. Methods: From September 2014 to July 2016, a surveillance study enrolled patients with acute febrile illness in ...
Monaíse M.O. Silva   +14 more
doaj   +1 more source

Chikungunya outbreak in Delhi, India, 2016: report on coinfection status and comorbid conditions in patients

open access: yesNew Microbes and New Infections, 2017
Chikungunya fever is a major public health issue in India affecting billions. After 2010, the infection was in a decline until in 2016, when a massive outbreak affected the country. In this report, we present serologic and molecular investigations of 600
N. Kaur   +8 more
doaj   +1 more source

Understanding the Biology and Immune Pathogenesis of Chikungunya Virus Infection for Diagnostic and Vaccine Development

open access: yesViruses, 2022
Chikungunya virus, the causative agent of chikungunya fever, is generally characterized by the sudden onset of symptoms, including fever, rash, myalgia, and headache.
Mohamad S. Hakim, Abu T. Aman
doaj   +1 more source

Intelligent Programmable Membrane Nanosponge for Early Virus Blocking

open access: yesAdvanced Science, EarlyView.
A smart programmable nanosponge (ACNPs) displays high‐density viral receptors on its membrane and encapsulates fusion inhibitors to capture virions at the infection source through competitive binding and blocks their entry through protease inhibition for ultra‐early cascade interception. This modular, mucus‐penetrating platform shifts antiviral defence
Ze Chen   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy